Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Armstrong, Nigel
928  Ergebnisse:
Personensuche X
?
1

KardiaMobile 6L for measuring QT interval in people having ..:

Westwood, Marie ; Armstrong, Nigel ; Posadzki, Pawel.
Health Technology Assessment.  , 2024
Link: https://doi.org/10.3310/..
 
?
2

Challenges in the Assessment of a Disease Model in the NICE..:

Scholte, Mirre ; Ramaekers, Bram ; Danopoulos, Evangelos...
PharmacoEconomics.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Software with artificial intelligence-derived algorithms fo..:

Westwood, Marie ; Ramaekers, Bram ; Grimm, Sabine...
Health Technology Assessment.  , 2024
Link: https://doi.org/10.3310/..
 
?
4

Bayesian Hierarchical Modelling for Histology-Independent T..:

Sugden, Bradley M. ; Grimm, Sabine E. ; Wolff, Robert...
PharmacoEconomics.  42 (2024)  6 - p. 615-618 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Abemaciclib in Combination with Endocrine Therapy for Adjuv..:

Orozco Leal, Giovany ; Armstrong, Nigel ; Kernohan, Ashleigh...
PharmacoEconomics.  41 (2023)  7 - p. 741-750 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Correction: Belimumab for Treating Active Autoantibody‑Posi..:

Otten, Thomas ; Riemsma, Rob ; Wijnen, Ben...
PharmacoEconomics.  41 (2023)  11 - p. 1551-1551 , 2023
Link: https://doi.org/10.1007/..
 
?
7

A systematic review of clinical effectiveness and safety fo..:

Armstrong, Nigel ; Olaye, Andrew ; Noake, Caro.
Orphanet Journal of Rare Diseases.  18 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

Filgotinib for Treating Moderately to Severely Active Ulcer..:

van Asselt, Antoinette D. I. ; Armstrong, Nigel ; Kimman, Merel...
PharmacoEconomics.  41 (2023)  3 - p. 239-251 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell..:

Al Khayat, Mohamed N. M. T. ; Armstrong, Nigel ; Howick, Jeremy...
PharmacoEconomics.  41 (2023)  4 - p. 353-361 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Oral Azacitidine for Maintenance Treatment of Acute Myeloid..:

Witlox, Willem ; Grimm, Sabine ; Howick, Jeremy...
PharmacoEconomics.  41 (2023)  8 - p. 857-867 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Correction to: Mogamulizumab for Previously Treated Mycosis..:

Grimm, Sabine E. ; Witlox, Willem ; Wolff, Robert...
PharmacoEconomics.  40 (2022)  5 - p. 575-575 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Fenfluramine for Treating Dravet Syndrome: An Evidence Revi..:

Wijnen, Ben ; Witlox, Willem ; Wolff, Robert...
PharmacoEconomics.  41 (2022)  1 - p. 33-42 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Belimumab for Treating Active Autoantibody-Positive Systemi..:

Otten, Thomas ; Riemsma, Rob ; Wijnen, Ben...
PharmacoEconomics.  40 (2022)  9 - p. 851-861 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Modeling the cost-effectiveness of prolonged-release fampri..:

Acosta, Carlos ; Gianinazzi, Mattia ; Dort, Thibaut...
Journal of Medical Economics.  24 (2021)  1 - p. 770-780 , 2021
Link: https://doi.org/10.1080/..
 
?
15

Mogamulizumab for Previously Treated Mycosis Fungoides and ..:

Grimm, Sabine E. ; Witlox, Willem ; Wolff, Robert...
PharmacoEconomics.  40 (2021)  5 - p. 509-518 , 2021
Link: https://doi.org/10.1007/..
 
1-15